Wolchok JD - Search Results

1

Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition.

Carvajal RD, Lawrence DP, Weber JS, Gajewski TF, Gonzalez R, Lutzky J, O'Day SJ, Hamid O, Wolchok JD, Chapman PB, Sullivan RJ, Teitcher JB, Ramaiya N, Giobbie-Hurder A, Antonescu CR, Heinrich MC, Bastian BC, Corless CL, Fletcher JA, Hodi FS. Carvajal RD, et al. Among authors: wolchok jd. Clin Cancer Res. 2015 May 15;21(10):2289-96. doi: 10.1158/1078-0432.CCR-14-1630. Epub 2015 Feb 18. Clin Cancer Res. 2015. PMID: 25695690 Free PMC article. Clinical Trial.

2

Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy.

Wolchok JD, Klimek VM, Williams L, Chapman PB. Wolchok JD, et al. Cytokines Cell Mol Ther. 1999 Dec;5(4):205-6. Cytokines Cell Mol Ther. 1999. PMID: 10850383

3

Systemic chemotherapy.

Klimek VM, Wolchok JD, Chapman PB, Houghton AN, Hwu WJ. Klimek VM, et al. Among authors: wolchok jd. Clin Plast Surg. 2000 Jul;27(3):451-61, ix-x. Clin Plast Surg. 2000. PMID: 10941565 Review.

4

Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope.

Wolchok JD, Chapman PB. Wolchok JD, et al. J Clin Oncol. 2002 Jul 15;20(14):3176; author reply 3176-7. doi: 10.1200/JCO.2002.20.14.3176. J Clin Oncol. 2002. PMID: 12118032 No abstract available.

5

Clinical results using biochemotherapy as a standard of care in advanced melanoma.

Chapman PB, Panageas KS, Williams L, Wolchok JD, Livingston PO, Quinn C, Hwu WJ. Chapman PB, et al. Among authors: wolchok jd. Melanoma Res. 2002 Aug;12(4):381-7. doi: 10.1097/00008390-200208000-00011. Melanoma Res. 2002. PMID: 12170188

6

Melanoma vaccines.

Perales MA, Wolchok JD. Perales MA, et al. Among authors: wolchok jd. Cancer Invest. 2002;20(7-8):1012-26. doi: 10.1081/cnv-120005918. Cancer Invest. 2002. PMID: 12449735 Review.

7

How can we tell when cancer vaccines vaccinate?

Wolchok JD, Chapman PB. Wolchok JD, et al. J Clin Oncol. 2003 Feb 15;21(4):586-7. doi: 10.1200/JCO.2003.12.065. J Clin Oncol. 2003. PMID: 12586792 No abstract available.

8

Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.

Bergman PJ, McKnight J, Novosad A, Charney S, Farrelly J, Craft D, Wulderk M, Jeffers Y, Sadelain M, Hohenhaus AE, Segal N, Gregor P, Engelhorn M, Riviere I, Houghton AN, Wolchok JD. Bergman PJ, et al. Among authors: wolchok jd. Clin Cancer Res. 2003 Apr;9(4):1284-90. Clin Cancer Res. 2003. PMID: 12684396 Clinical Trial.

9

Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma.

Wolchok JD, Williams L, Pinto JT, Fleisher M, Krown SE, Hwu WJ, Livingston PO, Chang C, Chapman PB. Wolchok JD, et al. Melanoma Res. 2003 Apr;13(2):189-96. doi: 10.1097/00008390-200304000-00013. Melanoma Res. 2003. PMID: 12690304 Clinical Trial.

10

Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.

Segal NH, Pavlidis P, Noble WS, Antonescu CR, Viale A, Wesley UV, Busam K, Gallardo H, DeSantis D, Brennan MF, Cordon-Cardo C, Wolchok JD, Houghton AN. Segal NH, et al. Among authors: wolchok jd. J Clin Oncol. 2003 May 1;21(9):1775-81. doi: 10.1200/JCO.2003.10.108. J Clin Oncol. 2003. PMID: 12721254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

481 results

Search Page

Filters